Aubrianne Alexa Rose is a Montrose, California based nurse practitioner. Active license number of Aubrianne Alexa Rose is 95022905 in California. Her current practice location is 2525 Honolulu Ave, Montrose. Patients can reach her at 818-484-8878 and her NPI number (Unique professional ID assigned by NPPES) is 1619692217. Aubrianne Alexa Rose has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.
Complete Profile:
Aubrianne Alexa Rose speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1619692217
NPI Enumeration Date:
05 Oct, 2022
NPI Last Update On:
05 Jan, 2023
Medical Licenses:
NPs can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Aubrianne Alexa Rose are as mentioned below.
License Number
Specialization
State
Status
95022905
California
Primary
95114077
Registered Nurse
California
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Aubrianne Alexa Rose 27956 Dexter Dr, Santa Clarita, California
Zip:
91350-3652
Phone Number:
818-751-3246
Patients can reach Aubrianne Alexa Rose at 2525 Honolulu Ave, Montrose, California or can call to book an appointment on 818-484-8878.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.